AngioDynamics, The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients with PE.
Learn More
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
The AlphaVac system is an off the shelf, easy to assemble, emergent mechanical aspiration device, allowing for efficient procedure time…
Today, localized therapy options are limited in providing physicians and patients with a customizable and confident treatment. Most options come…
Engineered with your practice and your patients in mind, The Auryon System is designed with industry-leading technology and features that…
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.
In the United States, an estimated 900,000 people are affected by a blood clot every year, yet they are often underdiagnosed. Visit with your doctor if you think you might be at risk.
Reference: https://www.cdc.gov/ncbddd/dvt/features/prevent-blood-clots.html
Congratulations to @vgallo83, Dr. Basem Azab, Dr. Sherley Dimitrius, & team at Staten Island University Hospital of @NorthwellHealth on completing their 1st procedure using the #NanoKnife System! We are grateful for your partnership!
Congratulations to Dr. Tim Grossman and team at @StPetersHelena on completing the first procedure using the #NanoKnife System in the state of MT! Thank you for your partnership & expanding treatment options for your patients.
Risk Info: https://www.angiodynamics.com/about-us/risk-information/
#IRE #Ablation
Check out the highlights from our most recent Endovascular Therapies for the Venous System Master Course! We are looking forward to sharing more insights, experiences, & best practices this weekend, live from Tampa, FL! @JonnyMoriarty @cardiowiis @DavidZlotnick1
AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.
Latham, NY (HQ)
Glens Falls, NY (Manufacturing)
Queensbury, NY (Manufacturing)
Marlborough, MA (R&D)
Amsterdam, NL (International HQ)
São Paulo, BR (Brazil Office)
Oakville, CA (Canada Office)
Hong Kong, HK (Asia Pacific Regional Office)
Rehovot, IL (Israel Office)
